The company said it will apply for U.S. approval for the treatment for a type of advanced blood cancer by the end of the year.
The study tested three dose levels of liso-cel in the 269 patients with relapsed or refractory large B-cell lymphoma. The data marks a win for Bristol-Myers after its purchase of Celgene met resistance from some investors who thought that it was overpaying for the cancer-focused biotech. Celgene had forecast annual sales reaching $3 billion for the immunotherapy. If approved, it would lessen some of Bristol-Myers’ dependence on its immunotherapy Opdivo, which has faced stiff competition from Merck & Co’s market leading rival drug Keytruda.
این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
Rescued miner in stable condition - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.The Tau Lekoa Gold Mine management says the fifth mine worker who was rescued on Friday following a rockfall that killed four miners is in a stable condition in hospital. Who is the CEO of this mine & the mining group owning Tau Lekoa?
منبع: SABC News Online - 🏆 32. / 51 ادامه مطلب »
Eskom implements stage six loadshedding - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.%Eskom says the incessant rains in various parts of the country are making it difficult for it to reduce loadshedding% Oh my God I am sick and tired of South Africa At this rate I think electricity should be free
منبع: SABC News Online - 🏆 32. / 51 ادامه مطلب »